Sang Hyun Park1, Soo Young Lee2, Soon Ae Kim3. 1. Department of Internal Medicine, School of Medicine, Eulji University, Daejeon, Republic of Korea. 2. Department of Pharmacology, School of Medicine, Eulji University, Daejeon, Republic of Korea. 3. Department of Pharmacology, School of Medicine, Eulji University, Daejeon, Republic of Korea sakim@eulji.ac.kr.
Abstract
BACKGROUND/AIM: Decreased mitochondrial DNA copy number (mtDNA-CN) has been associated with coronary artery disease (CAD). We aimed to clarify the difference between stable CAD (SCAD) and acute coronary syndrome (ACS) regarding mtDNA-CN and the DNA methylation ratio in regions influencing the regulation of mitochondrial biogenesis. MATERIALS AND METHODS: Using quantitative real-time polymerase chain reaction, mtDNA-CN was measured in peripheral blood leukocytes sampled from 50 patients with SCAD and 50 with ACS. We then conducted bisulfite modification of DNA followed by methylation-specific polymerase chain reaction to quantify mtDNA methylation in the mitochondrial D-loop region (mtDLR) and nuclear DNA methylation in the promoter region of nuclear peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A) gene. RESULTS: Compared to patients with SCAD, those with ACS had significantly lower relative mtDNA-CN (0.89±0.24 vs. 1.00±0.28, p=0.013) and higher DNA methylation ratio of the mtDLR (1.11±0.24 vs. 1.00±0.25, p=0.027) Conclusion: Our findings suggest that increased DNA methylation in the mtDLR, which translates into reduced mtDNA content, may affect the clinical phenotype of CAD. Copyright
BACKGROUND/AIM: Decreased mitochondrial DNA copy number (mtDNA-CN) has been associated with coronary artery disease (CAD). We aimed to clarify the difference between stable CAD (SCAD) and acute coronary syndrome (ACS) regarding mtDNA-CN and the DNA methylation ratio in regions influencing the regulation of mitochondrial biogenesis. MATERIALS AND METHODS: Using quantitative real-time polymerase chain reaction, mtDNA-CN was measured in peripheral blood leukocytes sampled from 50 patients with SCAD and 50 with ACS. We then conducted bisulfite modification of DNA followed by methylation-specific polymerase chain reaction to quantify mtDNA methylation in the mitochondrial D-loop region (mtDLR) and nuclear DNA methylation in the promoter region of nuclear peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A) gene. RESULTS: Compared to patients with SCAD, those with ACS had significantly lower relative mtDNA-CN (0.89±0.24 vs. 1.00±0.28, p=0.013) and higher DNA methylation ratio of the mtDLR (1.11±0.24 vs. 1.00±0.25, p=0.027) Conclusion: Our findings suggest that increased DNA methylation in the mtDLR, which translates into reduced mtDNA content, may affect the clinical phenotype of CAD. Copyright
Authors: Carlos Jose Pirola; Tomas Fernández Gianotti; Adriana Laura Burgueño; Manuel Rey-Funes; Cesar Fabian Loidl; Pablo Mallardi; Julio San Martino; Gustavo Osvaldo Castaño; S Sookoian Journal: Gut Date: 2012-08-09 Impact factor: 23.059
Authors: Scott W Ballinger; Cam Patterson; Cynthia A Knight-Lozano; David L Burow; Caryl A Conklin; Zhaoyong Hu; Johannes Reuf; Chris Horaist; Russell Lebovitz; Glenn C Hunter; Ken McIntyre; Marschall S Runge Journal: Circulation Date: 2002-07-30 Impact factor: 29.690
Authors: C W Hamm; J Ravkilde; W Gerhardt; P Jørgensen; E Peheim; L Ljungdahl; B Goldmann; H A Katus Journal: N Engl J Med Date: 1992-07-16 Impact factor: 91.245
Authors: Hyang-Min Byun; Tommaso Panni; Valeria Motta; Lifang Hou; Francesco Nordio; Pietro Apostoli; Pier Alberto Bertazzi; Andrea A Baccarelli Journal: Part Fibre Toxicol Date: 2013-05-08 Impact factor: 9.400